Live Breaking News & Updates on Immune Effector Cell

Stay updated with breaking news from Immune effector cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody

Expert panelists provide an overview of adverse events associated with bispecific antibodies for the treatment of multiple myeloma along with best practices for monitoring and treating adverse events. ....

Anthony Perissinotti , Ryan Haumschild , Matthew Pianko , Practice Pearls , Immune Effector Cell , Associated Encephalopathyscoring , Pharmacy Times , Multiple Myeloma , Bispecific Antibodies , Adverse Event Profile , Cytokine Release Syndrome , Immune Effector Cell Associated Neurotoxicity Syndrome ,

Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress

Incyte today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology Annual Meeting held. | May 25, 2023 ....

United Kingdom , United States , Tafasitamab Monjuvi , Ponatinib Iclusig , Steven Stein , Macrogenics Inc , American Society Of Clinical Oncology , International Blood , Marrow Transplant Research , Takeda Pharmaceuticals International , Lymphoma Biology Translational Research , Takeda Pharmaceutical Company , Drug Administration , European Union , Incyte Corporation , Millennium Pharmaceuticals Inc , Xencor Inc , European Hematology Association , Exchange Commission , Clinical Oncology , Annual Meeting , Hybrid Congress , Chief Medical Officer , Activin Receptor Like Kinase , Hematologic Malignancies , Myelodysplastic Syndromes ,

Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board

/PRNewswire/ Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced the. ....

United States , Jim Martinez , Anja Krammer , Kevinj Curran , Memorial Sloan Kettering Cancer Center , American Society Of Pediatric Hematology Oncology , Business Development Finance Committee , Stem Cell Engineering Committee , National Cancer Institute , American Society Of Hematology , Howard Hughes Medical Institute , International Society Of Cell Gene Therapy , Dysregulation Program , Medical Advisory , Sloan Kettering Cancer Center , Joseph Hai Oved , Turn Bio , Epigenetic Reprogramming , Immune Effector Cell , Program Director , Cell Therapy , Cell Engineering Facility , American Society , Memorial Sloan Kettering Cancer , Primary Immunodeficiency , Immune Dysregulation Program ,